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Abstract
Purpose: To evaluate the outcome of pars plana vitrectomy (PPV) in eyes with clinical signs of equine
recurrent uveitis (ERU) testing positive or negative for intravitreal antibodies against various serovars of
Leptospira interrogans. 47 eyes of horses with ERU in which intraoperative vitreous samples were
tested by microagglutination (MAT) for various serovars of Leptospira interrogans between 2001 and
2009 were included in a retrospective study. The presence or absence of postoperative ERU was
evaluated by repeated ocular examinations, as well as by interrogation of referring veterinarians and
owners. The absence of recurrent episodes of active uveitis was considered a success irrespective of the
visual performance of the operated eyes. 85% of eyes of horses with ERU had antibodies against L.
interrogans in their vitreous. The most common serovar was L. grippothyphosa. The majority of horses
testing positive for antibodies against L. interrogans (40/47; 82.5%) showed no further episodes of ERU,
while 6/7 (85.7%) of horses testing negative continued to experience episodes of ERU. This difference
is statistically significant. It appears that PPV is an effective treatment for Leptospira-associated ERU
but not for eyes testing negative for antibodies against L. interrogans. Vitreal and aqueous humor
samples of horses suffering from ERU should be tested by MAT before performing a PPV. Keywords:
Equine recurrent uveitis, vitrectomy, Leptospira interrogans, antibodies, ophthalmology
Introduction
Equine recurrent uveitis is one of the most common causes of
blindness in horses worldwide with a prevalence of 8 to 10% in
horses in Western Europe (Szemes and Gerhards 2000, Deeg
et al. 2002). There is mounting evidence, that various serovars
of Leptospira interrogans are at least the triggering factor for
ERU (Roberts et al. 1952, Yager et al. 1952, Bryans 1955,
Roberts 1958, Roberts 1969, Trap 1979, Hathaway et al. 1981,
Davidson et al. 1987, Matthews et al. 1987, Sillerud et al.
1987, Dwyer et al. 1995, Wollanke et al. 1998, Wollanke et al.
2001, Wollanke 2002, Wollanke et al. 2004a, Niedermaier et
al. 2006, Gilger Salmon et al. 2008) and it has been shown,
that vaccination with a specific vaccine was successful in pre-
venting new cases in an endemic horse population (Rohrbach et
al. 2002, Wollanke et al. 2004b, Rohrbach et al. 2005). 
ERU is the most common form of uveitis seen in horses. The
clinical presentation is variable. The vast majority of horses are
presented with clinical signs of anterior uveitis, which are easi-
ly recognizable by owners and referring veterinarians. Some of
them may also have Panuveitis, although examination of the
posterior segment is initially precluded by the intense miosis. A
small number of patients exhibit a less obvious form of ERU,
usually intermediate uveitis (pars planitis) with marked inflam-
matory changes of the posterior segment (vitreous). Since the
clinical signs are subtle in these cases, they are usually only
presented because of visual deficits at a late stage of the dise-
ase. There appears to be no correlation between the form of
uveitis and the Leptospira status of an individual patient
(Tömördy 2009). The association between peripapillary cho-
roidal degeneration (butterfly lesions) and ERU is unclear (Mat-
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Summary
Purpose: To evaluate the outcome of pars plana vitrectomy (PPV) in eyes with clinical signs of equine recurrent uveitis (ERU) testing positi-
ve or negative for intravitreal antibodies against various serovars of Leptospira interrogans. 47 eyes of horses with ERU in which intraope-
rative vitreous samples were tested by microagglutination (MAT) for various serovars of Leptospira interrogans between 2001 and 2009
were included in a retrospective study. The presence or absence of postoperative ERU was evaluated by repeated ocular examinations, as
well as by interrogation of referring veterinarians and owners. The absence of recurrent episodes of active uveitis was considered a suc-
cess irrespective of the visual performance of the operated eyes. 85% of eyes of horses with ERU had antibodies against L. interrogans in
their vitreous. The most common serovar was L. grippothyphosa. The majority of horses testing positive for antibodies against L. interro-
gans (40/47; 82.5%) showed no further episodes of ERU, while 6/7 (85.7%) of horses testing negative continued to experience episodes
of ERU. This difference is statistically significant. It appears that PPV is an effective treatment for Leptospira-associated ERU but not for eyes
testing negative for antibodies against L. interrogans. Vitreal and aqueous humor samples of horses suffering from ERU should be tested
by MAT before performing a PPV.
Keywords: Equine recurrent uveitis, vitrectomy, Leptospira interrogans, antibodies, ophthalmology
Die Resultate der Pars-Plana-Vitrektomie bei Pferden mit rezidivierender Uveitis in Abhängigkeit von Antikörpern gegen ver-
schiedene Serotypen von Leptospira interrogans im Glaskörper
Die Untersuchung sollte einen möglichen Zusammenhangs zwischen dem Erfolg der Pars Plana Vitrektomie (PPV) und dem Vorhandensein
von intravitrealen Antikörper gegen verschiedene Serotypen von Leptospira interrogans bei Pferden mit equiner rezidivierender Uveitis (ERU)
klären. In einer retrospektiven Studie wurden zwischen 2001 und 2009 intraoperative Glaskörperproben von 47 Augen mit ERU mittels
Mikroagglutinationstest (MAT) auf Antikörper gegen verschiedene Serovars von L. interrogans untersucht. Das Wiederauftreten von ERU
nach der PPV wurde durch wiederholte Augenuntersuchungen, sowie durch Befragungen überweisender Tierärzte und Pferdebesitzer
ermittelt. Das Fehlen von rezidivierenden Uveitisschüben nach der Vitrektomie wurde als Therapieerfolg eingestuft, unabhängig von der
Sehleistung des betroffenen Auges. 85% der Augen von Pferden mit ERU hatten intravitreale Antikörper gegen L. interrogans. Die häufig-
ste Serotyp war L. grippothyphosa. Die Mehrheit der Pferde (40/47; 85.5%), welche positiv auf Antikörper gegen Leptospira spp. waren,
zeigten postoperativ keine Entzündungsschübe mehr, während 6/7 (85.7%) der Augen mit negativem Test weiterhin Uveitis zeigten. Dieser
Unterschied ist signifikant. Es scheint, dass PPV eine Erfolg versprechende Behandlungsmethode ist für Pferde mit Leptospiren-assoziierter
ERU, aber nicht für Pferde, welche negativ sind für Antikörper gegen L. interrogans. Vor einer allfälligen chirurgischen Behandlung sollten
Kammerwasser- und Glaskörperproben auf Antikörper gegen Leptospiren spp. untersucht werden.
Schlüsselwörter: Equine rezidivierende Uveitis, Vitrektomie, Leptospira interrogans, Antikörper, Ophthalmologie
thews et al. 1990). However, in ponies experimentally infected
with Leptospira spp. peripapillary chorioretinitis developed
along with anterior uveitis (Williams et al. 1971). The diagno-
sis of ERU is based on the clinical signs of uveitis and a docu-
mented history of recurrent episodes of inflammation. In cen-
tral Europe it is prudent to consider any equine uveitis to be
ERU until proven otherwise. There are of course, other forms
of uveitis, especially those associated with blunt or sharp trau-
ma (Habin 1994, Moore et al. 1998, Grahn and Cullen
2000). Iridocyclitis and chorioretinitis have been seen in foals
with septicemia (Latimer and Wyman 1985), and we have
seen bilateral anterior uveitis in a foal with an umbilical infec-
tion and bacteremia. Uveitis may also be the result of multi-
centric neoplasms (Germann et al. 2008). Most forms of equi-
ne ulcerative keratitis are accompanied by some degree of
anterior uveitis (Nasisse and Nelms 1992).
Symptomatic treatment of ERU  (i.e., corticosteroids, mydria-
tics, and non-steroidal anti-inflammatory medications) aims
to reduce inflammation and minimize permanent ocular
damage at each episode of active uveitis, but it is not effecti-
ve in preventing recurrence of disease. Corticosteroids are
used topically or subconjunctivally, together with topical 1%
atropine sulfate. Non-steroidal anti-inflammatory medica-
tions are usually given systemically.  Intracameral injection of
tissue plasminogen activator (tpa) may be used to dissolve
organized fibrinous exudates in the anterior chamber (Spiess
1997). Other medications, such as aspirin, phenylbutazone,
used by some clinicians to possibly prevent or decrease seve-
rity of recurrent episodes of uveitis have limited efficacy and
potential detrimental side effects when used chronically in the
horse.
Most veterinary ophthalmologists agree that long-term pro-
gnosis for ERU with medical therapy alone is poor. Even
aggressive therapy is often insufficient to prevent recurrent
painful inflammatory episodes. Cumulative intraocular
damage often leads to phthisis bulbi, glaucoma, or loss of
vision as a result of cataract formation or retinal detachment.
Pars plana vitrectomy (PPV) has first been described in 1991
for the management of equine recurrent uveitis (Werry and
Gerhards 1991). PPV has since been increasingly employed
in the treatment of ERU in Europe (Werry and Gerhards
1991, Winterberg 1997, Frühauf et al. 1998, Gilger and
Spiess 2006). 
In a study of 43 eyes post PPV, 42 remained free of recurrent
uveitis during the follow-up period of 67 months. 70% of the-
se eyes retained some vision. The most common complica-
tion was cataract formation in 19/43 (44%!) eyes, followed
by phthisis bulbi in 6 eyes, and retinal detachment in 4 eyes
(Winterberg 1997). In another study of 38 cases 5 eyes sho-
wed recurrence of uveitis between 10 days and 3 years post-
operatively (Frühauf et al. 1998). Thirty-three eyes showed no
recurrence during a follow-up period of up to 5 years. Vision
remained stable in 28 eyes and improved in one eye. The
remaining eyes showed marked vision loss as a result of cata-
racts (3), phthisis bulbi (1), or unknown cause (1). Of the 5
eyes with recurrent uveitis 2 demonstrated marked loss of
vision, while 3 maintained preoperative vision. 
In the present retrospective study we evaluated the outcome
of PPV in relation to the Leptospira spp. status of each patient.
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Animals, materials and methods
Between March 2001 and March 2009 59 eyes of 54 horses
with ERU underwent a vitrectomy procedure. There were 23
mares, 28 geldings and 3 stallions representing 23 breeds. Five
horses were operated bilaterally. Six unilaterally operated hor-
ses were lost to follow-up, leaving 53 eyes in the study for which
follow-up information was available. The follow-up period ran-
ged from 3 months to 7.5 years. The results of microagglutina-
tion tests (MAT) for various serovars of Leptospira interrogans
were available for 47 eyes. Diluted vitreous samples were col-
lected at the time of surgery and submitted to MAT1.
The outcome of vitrectomy was evaluated with regards to the
Leptospira-status of the individual patient. The presence or
absence of postoperative ERU was determined by repeated
ocular examinations, as well as by interrogation of referring
veterinarians and owners. A vitrectomy was considered suc-
cessful if no recurrent episodes of active uveitis were obser-
ved during the follow-up period. Visual performance was not
assessed and patients with mature cataracts but no recurrent
uveitis were listed as successful.
Data editing and all the statistical analyses were done using
Stata Software2. Analyses were carried out using the clrchi2
command. A p-value of ≤  .05 was considered as significant.
If not otherwise mentioned, a power of > .8 was considered.
Results
Forty of the 47 (85%) horses with ERU tested positive for Lep-
tospira antibodies by MAT. Only 7 horses tested negative. For
6 horses this information was not available. The following
serovars were identified in order of decreasing frequency: L.
grippothyphosa, L. pomona, L. canicola, L. bratislava, L.
pyrogenes, L. copenhageni, L. icterohaemorrhagiae, L. sax-
koebing, L. javanica, L. tarassovi  (Table 1). Most horses
tested positive for more than one serovar. The overall success
rate after vitrectomy (no recurrent uveitis) was 73,6%. The
remaining 26,4% of patients experienced one or more episo-
de of active uveitis postoperatively. 
Of the 40 horses testing positive for Leptospira 33 (82.5%)
showed no further uveitis, while the remaining 7 (17.5%) had
at least one documented relapse of uveitis.
Of the seven horses testing negative for Leptospira antibo-
dies, only 1 (14.3%) was considered a success, while the
remaining 6 (85,7%) patients continued to show recurrent
episodes of uveitis (Table 2).
Discussion
The most important goal of therapy for ERU is to prevent recur-
rent painful episodes of active uveitis. In addition, therapy
should aim at preserving, restoring or at least stabilizing vision.
For the purpose of this retrospective study the absence of
recurrent episodes of active uveitis was considered a success. 
Medical therapy alone is usually insufficient to prevent recurrent
uveitis on a long-term basis. PPV has proven to be an effective
surgical therapy for ERU with a high success rate (Winterberg
1997, Fruhauf et al. 1998, Gilger and Spiess 2006). 
The role of Leptospira interrogans in the pathophysiology of
ERU has been cause for controversy. While some authors con-
sider ERU to be a purely immune-mediated disease (Hines and
Halliwell 1991, Deeg et al. 2001, Deeg et al. 2002a, Deeg et
al. 2002b, Deeg et al. 2004, Deeg et al. 2006a, Deeg et al.
2006b, Deeg et al. 2007a, Deeg et al. 2007b, Deeg et al.
2007c, Deeg 2008, Deeg et al. 2008), others consider Lepto-
spira to be the cause or at least the triggering factor for ERU
(Matthews et al. 1987, Brem et al. 1998, Wollanke et al. 1998,
Brem et al. 1999, Faber et al. 2000, Rohrbach et al. 2002,
Wollanke 2004a, Wollanke 2004b, Rohrbach et al. 2005).
In our caseload 85% of horses with clinical signs of ERU have
Leptospira antibodies in the vitreous of the affected eyes. In a
study in Great Britain, only 11.1% of horses with uveitis had
positive titers against L. interrogans antibodies (Matthews et
al. 1987). The most common serovar was L. sejroe. In our
study the most common serovar of L. interrogans was grip-
pothyphosa followed by pomona, canicola, and bratislava.
This is in accordance with another study from continental
Europe (Brem et al. 1999). Similar reports from North Ame-
rica identified most commonly L. interrogans serovar pomo-
na (Halliwell et al. 1985, Dwyer et al. 1995).
The most important result of the present study was the signifi-
cantly different outcome of PPV of horses testing positive or
negative for L. interrogans antibodies. It is interesting to note,
that the vast majority of eyes testing negative experienced
recurrent episodes of ERU postoperatively. In view of theses
findings we now routinely submit serum, aqueous humor and
vitreous samples of eyes with clinical signs of ERU for MAT for
Leptospira interrogans antibodies before deciding to perform
a PPV. Of 10 eyes testing positive, 9(90%) had no further
recurrence of ERU (Spiess, in preparation). These numbers are
still too small to draw any conclusions. In future studies the
presence of Leptospira in the vitreous of horses with ERU
should be determined by PCR. Preoperative testing of a larger
number of horses should show, whether the present assump-
tion that PPV is primarily successful in cases of Leptospira-
E. Tömördy et al.
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associated ERU is true. In a prospective study, the optimal tre-
atment for horses with ERU not associated with Leptospira spp.
should be evaluated. It is possible, that these horses benefit
from the suprachoroidal implantation of a CSA-releasing devi-
ce (Gilger et al. 2000a, Gilger et al. 2000b, Gilger et al.
2001, Gilger and Spiess 2006, Gilger et al. 2006).
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